Comparison of postoperative nausea and vomiting with remimazolam and propofol
Not Applicable
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000044442
- Lead Sponsor
- Suwa Red-Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Contraindication to application of both remimazolam besylate and propofol. Contraindication to regional anesthesia. BMI higher than 35 kg/m2.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of postoperative nausea and vomiting from immediately after surgery to the second postoperative day.
- Secondary Outcome Measures
Name Time Method Comparison of vascular pain, circulatory depression (bradycardia, hypotension), intraoperative arousal, and postoperative complications (respiratory depression, delayed arousal, delirium, shivering, erythema and headache).